Search | IOVS | ARVO Journals

Showing 1 – 20 of 26

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

In vitro immunomodulatory capacity of Lactoferrin liposomes

Lorena Bonilla Vidal; Elena Sánchez López; Martina Biancardi; Anna Rita Blanco; Gerard Esteruelas; Ana Laura López-Machado; Josefa Badia; Laura Baldomà; Aldo Vagge; María Luisa García; Giuseppe Giannaccare

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3602.

ARVO Annual Meeting Abstract June 2024

Lactoferrin liposomal eyedrops: physicochemical characterization, cytotoxicity and ocular tolerance

Elena Sánchez López; Lorena Bonilla Vidal; Gerard Esteruelas; Martina Biancardi; Anna Rita Blanco; Ana Laura López-Machado; Marta Espina; Aldo Vagge; Giuseppe Giannaccare; María Luisa García

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3604.

ARVO Annual Meeting Abstract June 2024

VIAN-c4551 in eye drops inhibits the excessive retinal vasopermeability induced by VEGF and diabetes in rodents

Elva Adán Castro; Juan Pablo Robles; Magdalena Zamora; Lourdes Siqueiros-Márquez; Daniela Granados-Carrasco; Jose Fernando García-Rodrigo; Marlon García-Roa; Ellery López-Star; Thomas Bertsch; Jakob Triebel; Gonzalo Martinez de la Escalera; Carmen Clapp

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6236.

ARVO Annual Meeting Abstract June 2023

Levosulpiride for the treatment of diabetic macular edema: A phase 2, randomized, pilot clinical trial

Mariana Edith López Hernánez; Maria Del Carmen Clapp; Carlos Nuñez; Elva Adán- Castro; Renata García; Marlon García Roa; Juan Fernando Rubio Mijangos; Jorge Sánchez; Gabriela Ramírez Hernández; Nundehui Diaz Lezama; Ellery López Star; Thomas Bertsch; Gonzálo Martínez de la Escalera; Jakob Triebel; Nayeli Piñeiro; Monserrat Siqueiros

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2657.

ARVO Annual Meeting Abstract June 2022

Evaluating the Qualitative Features of Occular Surface Dry Eye Disease using a Novel Confocal Microscopy Imaging Protocol

Adrian C Tsang; Jeremy Nortey; Sarah E Lopez; John Alexander Gonzales; Jeremy D Keenan

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1229 – A0229.

Articles August 2020

Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy

PDF

Carlos D. Nuñez-Amaro; Aura Ileana Moreno-Vega; Elva Adan-Castro; Magdalena Zamora; Renata Garcia-Franco; Paulina Ramirez-Neria; Marlon Garcia-Roa; Yolanda Villalpando; Juan Pablo Robles; Gabriela Ramirez-Hernandez; Mariana Lopez; Jorge Sanchez; Ellery Lopez-Star; Thomas Bertsch; Gonzalo Martinez de la Escalera; Ma. Ludivina Robles-Osorio; Jakob Triebel; Carmen Clapp
TAGS: angiogenesis inhibitors, diabetes mellitus, prolactin, vitreous body, proliferative diabetic retinopathy, hyperprolactinemia, placebos
Trans. Vis. Sci. Tech.. 2020; 9(9):27. https://doi.org/10.1167/tvst.9.9.27

ARVO Annual Meeting Abstract June 2020

Evaluation of the effectiveness of using OCT during the initial assessment to detect glaucoma and macular conditions

Van C Lansingh; Bethania Lopez-Star; Felipe de Jesus Ramirez Solis; Luis Andrés Ochoa-Ramirez; Ellery Marino Lopez-Star

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2552.

ARVO Annual Meeting Abstract July 2019

Telemedicine screening for retinopathy of prematurity (ROP) using digital retinal images: A pilot study.

Alejandro Arias Gómez; Renata García Franco; Paulina Ramírez Neria; Dalia Méndez Marín; Van Charles Lansingh; Ellery López Star; Ximena Mira Lorenzo; Verónica Romero Morales; Marlon García Roa; Yolanda Villalpando Gómez; Miguel Vazquez Membrillo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6532.

ARVO Annual Meeting Abstract July 2019

Screening for diabetic retinopathy and other retinal diseases: a telemedicine project in Mexico

Dalia Méndez Marín; Renata García Franco; Van Charles Lansingh; Ellery López Star; Alejandro Arias Gómez; Paulina Ramírez Neria; Marlon García Roa; Verónica Romero Morales; Ximena Mira Lorenzo; Miguel Vazquez Membrillo; Yolanda Villalpando Gómez

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1101.

ARVO Annual Meeting Abstract July 2018

Translating Population Based Research Data Into Actionable Steps

Van C Lansingh; Ellery Marino Lopez - Star

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4104.

ARVO Annual Meeting Abstract June 2017

ALPHA-1-ANTITRYPSIN REDUCE LEVELS OF TUMOR NECROSIS FACTOR ALPHA BOTH IN VITRO AND IN VIVO DIABETES MODELS.

Juan E Gallo; Gustavo Ortiz; MARÍA CONSTANZA POTILINSKI; Juan Pablo Salica; Emiliano S Lopez; Eduardo Chuluyan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5805.

ARVO Annual Meeting Abstract June 2017

Staging of diabetic retinopathy in a sample of patients in Mexico through a reading center.

Hugo Valencia-Santiago; Miguel Vazquez; Ellery Lopez-Star; Charles Van-Lansingh; Veronica Romero; Ximena Mira; Renata Garcia Franco

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2904.

ARVO Annual Meeting Abstract March 2012

Suramab Strongly Inhibits Neovascularization Through Downregulation of VEGF, FGF and P2X2 receptor

Emiliano S. Lopez; Juan O. Croxatto; Juan E. Gallo

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2400.

Genetics October 2011

WDR36 and P53 Gene Variants and Susceptibility to Primary Open-Angle Glaucoma: Analysis of Gene-Gene Interactions

PDF

Cristina Blanco-Marchite; Francisco Sánchez-Sánchez; María-Pilar López-Garrido; Mercedes Iñigez-de-Onzoño; Francisco López-Martínez; Enrique López-Sánchez; Lydia Alvarez; Pedro-Pablo Rodríguez-Calvo; Carmen Méndez-Hernández; Luis Fernández-Vega; Julián García-Sánchez; Miguel Coca-Prados; Julián García-Feijoo; Julio Escribano
TAGS: disease susceptibility, gene interaction, open-angle glaucoma, wdr36 gene, glaucoma
Invest. Ophthalmol. Vis. Sci.. 2011; 52(11):8467-8478. https://doi.org/10.1167/iovs.11-7489

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2011

Poloxamer Improves the Duration of Action of Suramab to Inhibit Corneal Angiogenesis

Emiliano S. Lopez; Juan Croxatto; Juan E. Gallo; Nanomedicine & Vision Group, Universidad Austral,Buenos Aires, Argentina

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6383.

ARVO Annual Meeting Abstract April 2011

Analysis Of Apoptotic Proteome In Primary Pterygium

Victor M. Bautista, Sr.; Nadia Luz López-Espinoza; Miriam Edith López-Salas

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3366.

ARVO Annual Meeting Abstract April 2010

Suramab Strongly Inhibits Lymphangiogenesis and Angiogenesis in the Cornea

E. S. Lopez; O. J. Croxatto; J. E. Gallo

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5694.

ARVO Annual Meeting Abstract April 2010

Doxycycline Enhances Apoptosis and Increases TNF-Alpha Expression in Pterygial Fibroblasts

Y. Garfias; M. Vazquez-Membrillo; A. Rojas-Diaz; X. Mira; A. Robles-Contreras; E. Lopez-Star; M. C. Jimenez-Martinez; V. M. Bautista

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2400.

ARVO Annual Meeting Abstract April 2009

Subconjunctival Suramab Inhibits Corneal Neovascularization

E. S. Lopez; A. Kvanta,; J. Croxatto; J. Gallo

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4963.

ARVO Annual Meeting Abstract May 2008

Suramab, a Pharmaceutical Compound of Bevacizumab and Suramin, Strongly Inhibits Vessels Growth in a Rabbit Model of Corneal Neovascularization

E. S. Lopez; J. Croxatto; A. Kvanta; J. Gallo

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1491.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

In vitro immunomodulatory capacity of Lactoferrin liposomes

Lactoferrin liposomal eyedrops: physicochemical characterization, cytotoxicity and ocular tolerance

VIAN-c4551 in eye drops inhibits the excessive retinal vasopermeability induced by VEGF and diabetes in rodents

Levosulpiride for the treatment of diabetic macular edema: A phase 2, randomized, pilot clinical trial

Evaluating the Qualitative Features of Occular Surface Dry Eye Disease using a Novel Confocal Microscopy Imaging Protocol

Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy

Evaluation of the effectiveness of using OCT during the initial assessment to detect glaucoma and macular conditions

Telemedicine screening for retinopathy of prematurity (ROP) using digital retinal images: A pilot study.

Screening for diabetic retinopathy and other retinal diseases: a telemedicine project in Mexico

Translating Population Based Research Data Into Actionable Steps

ALPHA-1-ANTITRYPSIN REDUCE LEVELS OF TUMOR NECROSIS FACTOR ALPHA BOTH IN VITRO AND IN VIVO DIABETES MODELS.

Staging of diabetic retinopathy in a sample of patients in Mexico through a reading center.

Suramab Strongly Inhibits Neovascularization Through Downregulation of VEGF, FGF and P2X2 receptor

WDR36 and P53 Gene Variants and Susceptibility to Primary Open-Angle Glaucoma: Analysis of Gene-Gene Interactions

Poloxamer Improves the Duration of Action of Suramab to Inhibit Corneal Angiogenesis

Analysis Of Apoptotic Proteome In Primary Pterygium

Suramab Strongly Inhibits Lymphangiogenesis and Angiogenesis in the Cornea

Doxycycline Enhances Apoptosis and Increases TNF-Alpha Expression in Pterygial Fibroblasts

Subconjunctival Suramab Inhibits Corneal Neovascularization

Suramab, a Pharmaceutical Compound of Bevacizumab and Suramin, Strongly Inhibits Vessels Growth in a Rabbit Model of Corneal Neovascularization

To View More...

You must be signed into an individual account to use this feature.